A team of European and American researchers calls for randomized controlled trials in order to more robustly investigate this minimally invasive procedure for treatment.In both men and women, lung cancer causes the most cancer deaths, and 80% of these are non-small-cell lung cancer (NSCLC). ...
Only a minority of thyroid cancer patients develop locally recurrent or metastatic disease that is not curable with local therapy or I-131 treatment. However, treatment options for this small cohort have been limited; the only FDA-approved chemotherapy agent for thyroid cancer is adriamycin, which ...
WASHINGTON, May 10 (Xinhua) -- A team of cancer researchers managed to exploit a vulnerability in melanoma that has developed resistance to a targeted therapy, providing a potential new therapeutic strategy to selectively kill the drug-resistant cancer cells. The study published on Thursday in the...
The researchers also did testing in an animal model in which mice with pancreatic cancer were divided into six treatment groups, with mice receiving either regular CPD100; liposomal CPD100; vinblastine; gemcitabine, or GEM, a standard-of-care drug for PDAC patients; liposomal CPD100 plus GEM; ...
co-author of the study, shared his thoughts: “This study elucidates that the combination of immunotherapy and anti-vascular therapy can serve as a viable treatment strategy for advanced gastric and esophageal cancer beyond second-line therapy, thereby holding significant implications for large-scale ...
After the treatment, all of this patient's cancer disappeared and has not returned more than 22 months later. "If confirmed in a larger study, it promises to further extend the reach of this T-cell therapy to a broader spectrum of cancers," said Tom Misteli, director of CCR at NCI. ...
New bacterial therapy approach to treat lung cancer治疗肺癌的新细菌疗法方法 souyou 科研新闻,不定期更新!肺癌是美国和世界上最致命的癌症。目前许多可用的治疗方法都是无效的,留给病人的选择非常少。一种有希望的治疗癌症的新策略是细菌疗法,但尽管这种治疗方式在过去五年中已经从实验室实验迅速发展到临床试验,...
The paper's co-author Shiladitya Sengupta at Brigham and Women's Hospital said, "We can actually see macrophages eating cancer cells," citing confocal microscopy images in the paper that show macrophages engulfing cancer cells. Kulkarni said next steps are to continue testing the new therapy in ...
The best-studied PARPs generate PAR modifications and include PARP1 and the tankyrase PARP5A, both of which are targets for cancer therapy with inhibitors in either clinical trials or preclinical development. There are 15 additional PARPs, most of which modify proteins with MAR, and their biology...
Summary: anti-tumor immune cells is a new treatment for cancer, compared to traditional three kinds of therapy has its unique advantages of the use of their own cells to kill cancer cells in order to more. This article focuses on the concept of immune cells, classification, principles of ant...